Chemoenzymatic synthesis of sialoglyeopoh peptides as glycomimetics to block infection by avian and human influenza viruses

Bioconjugate Chemistry

Volumn 20, Issue 3, 2009, Pages 538-549

  Ogata, Makoto ^a   Hidari, Kazuya I P J ^b   Murata, Takeomi ^a   Shimada, Shizumi ^b   Kozaki, Wataru ^a   Park, Enoch Y ^a   Suzuki, Takashi ^b   Usui, Taichi ^a  

^a SHIZUOKA UNIVERSITY   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUSES;

ALKYL CHAIN; ALTERNATIVE DESIGNS; AVIAN INFLUENZA VIRUS; CHEMO-ENZYMATIC SYNTHESIS; GLYCANS; GLYCOMIMETICS; HUMAN INFLUENZA VIRUS; INFLUENZA VIRUS; POLYGLUTAMIC ACIDS; STRUCTURE-ACTIVITY RELATIONSHIPS;

POLYSACCHARIDES;

GLUTAMIC ACID; GLYCOSIDE; OLIGOSACCHARIDE; SIALIC ACID; SIALOGLYCOPOLYPEPTIDE; UNCLASSIFIED DRUG; AMINOSUGAR; ANTIVIRUS AGENT; HEMAGGLUTININ; N ACETYLLACTOSAMINE; N-ACETYLLACTOSAMINE; POLYGLUTAMIC ACID; POLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; AVIAN INFLUENZA; CELL STRAIN; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME ASSAY; FEMALE; HEMAGGLUTINATION INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC 50; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N3; INFLUENZA VIRUS A H7N2; KAPLAN MEIER METHOD; MOUSE; NONHUMAN; POLYMERIZATION; STRUCTURE ACTIVITY RELATION; SURVIVAL TIME; VIRUS ATTACHMENT; VIRUS INFECTIVITY; VIRUS INHIBITION; WEIGHT CHANGE; ANIMAL; BAGG ALBINO MOUSE; BIRD; CELL LINE; CHEMISTRY; DRUG EFFECT; HUMAN; METABOLISM; ORTHOMYXOVIRUS; SYNTHESIS; VIROLOGY;

AVES; HUMAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE;

AMINO SUGARS; ANIMALS; ANTIVIRAL AGENTS; BIRDS; CELL LINE; FEMALE; HEMAGGLUTININS; HUMANS; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE; POLYGLUTAMIC ACID; POLYSACCHARIDES;

EID: 63749132430     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc800460p     Document Type: Article

References (36)

1. Paulson, J. C, Sadler, J., and Hill, R. L. (1979) Restoration of specific myxovirus receptors to asialoerythrocytes by incorporation of sialic acid with pure sialyltransferases. J. Biol. Chem. 254, 2120-2124.
2. Suzuki, Y., Nagano, Y., Kato, H., Matsumoto, M., Nerome, K., Nakajima, K., and Nobusawa, E. (1986) Human influenza A virus hemagglutinin distinguishes sialyloligosaccharides in membrane-associated gangliosides as its receptor which mediates the adsorption and fusion processes of virus infection. J. Biol. Chem. 261, 17057-17061.
3. Rogers, G. N., and D'Souza, B. L. (1989) Receptor binding properties of human and animal HI influenza virus isolates. Virology 173, 317-322.
4. Gambaryan, A. S., Tuzikov, A. B., Piskarev, V. E., Yamnikova, S. S., Lvov, D. K., Robertson, J. S., Bovin, N. V., and Matrosovich, M. N. (1997) Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic sialylglycopolymers: non-egg-adapted human HI and H3 influenza A and B viruses share a common high binding affinity for 6′-sialyl(N-acetyllactosamine). Virology 232, 345-350.
5. Schengrund, C.-L. (2003) "Multivalent" saccharides: development of new approaches for inhibiting the effects of glycosphingolipid-binding pathogens. Biochem. Pharmacol. 65, 699-707.
6. Ogata, M., Murata, T., Murakami, K., Suzuki, T., Hidari, K. I.-P.J., Suzuki, Y., and Usui, T. (2007) Chemoenzymatic synthesis of artificial glycopolypeptides containing multivalent sialyloligosaccharides with a γ-polyglutamic acid backbone and their effect on inhibition of infection by influenza viruses. Bioorg. Med. Chem. 15, 1383-1393.
7. Suzuki, Y. (1994) Gangliosides as influenza virus receptors. Variation of influenza viruses and their recognition of the receptor sialo-sugar chains. Prog. Lipid Res. 33, 429-457.
8. Hidari, K. I.-P.J., Shirnada, S., Suzuki, Y., and Suzuki, T. (2007) Binding kinetics of influenza viruses to sialic acid-containing carbohydrates. Glycoconj. J. 24, 583-590.
9. Yamada, S., Suzuki, Y., Suzuki, T., Li, M. Q., Nidom, C. A., Sakai-Tagawa, Y., Muramoto, Y., Ito, M., Kiso, M., Hiromoto, T., Shinya, K., Sawada, T., Kiso, M., Usui, T., Murata, T., Lin, Y., Hay, A., Haire, L. F., Stevens, D. J., Russell, R. J., Gamblin, S. J., Skehel, J. J., and Kawaoka, Y. (2006) Hemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 444, 378-382.
10. 3)GlcNAc-containing receptors. Virology 326, 310-316.
11. Wu, W.-Y., Jin, B., Krippner, G. Y., and Watson, K. G. (2000) Synthesis of a polymeric 4-N-linked sialoside which inhibits influenza virus hemagglutinin. Bioorg. Med. Chem. Lett. 10, 341-343.
12. Tsuchida, A., Kobayashi, K., Matsubara, N., Muramatsu, T., Suzuki, T., and Suzuki, Y. (1998) Simple synthesis of sialyl-lactose-carrying polystyrene and its binding with influenza virus. Glycoconj. J. 15, 1047-1054.
13. Ohta, T., Miura, N., Fujitani, N., Nakajima, F., Niikura, K., Sadamoto, R., Guo, C.-T., Suzuki, T., Suzuki, Y., Monde, K., and Nishimura, S.-I. (2003) Glycotentacles: synthesis of cyclic glycopeptides, toward a tailored blocker of influenza virus hemagglutinin. Angew. Chem., Int. Ed. 42, 5186-5189.
14. Choi, S.-K., Mammen, M., and Whitesides, G. M. (1997) Generation and in situ evaluation of libraries of poly(acrylic acid) presenting sialosides as side chains as polyvalent inhibitors of influenza-mediated hemagglutination. J. Am. Chem. Soc. 119, 4103-4111.
15. Umemura, M., Itoh, M., Makimura, Y., Yamazaki, K., Umekawa, M., Masui, A., Matahira, Y., Shibata, M., Ashida, H., and Yamamoto, K. (2008) Design of a sialylglycopolymer with a chitosan backbone having efficient inhibitory activity against influenza virus infection. J. Med. Chem. 51, 4496-4503.
16. Totani, K., Kubota, T., Kuroda, T., Murata, T., Hidari, K. I.-P.J., Suzuki, T., Suzuki, Y., Kobayashi, K., Ashida, H., Yamamoto, K., and Usui, T. (2003) Chemoenzymatic synthesis and application of glycopolymers containing multivalent sialyloli-gosaccharides with a poly(L-glutamic acid) backbone for inhibition of infection by influenza viruses. Glycobiology 13, 315-326.
17. Sigal, G. B., Mammen, M., Dahmann, G, and Whitesides, G. M. (1996) Polyacrylamides bearing pendant a-sialoside groups strongly inhibit agglutination of erythrocytes by influenza virus: The strong inhibition reflects enhanced binding through cooperative polyvalent interactions. J. Am. Chem. Soc. 118, 3789-3800.
18. Gamian, A., Chomik, M., Laferriere, C. A., and Roy, R. (1991) Inhibition on influenza A virus hemagglutinin and induction by synthetic sialylated glycoconjugates. Can. J. Microbiol. 37, 233-237.
19. Spaltenstein, A., and Whitesides, G. M. (1991) Polyacryla-mides bearing pendant α-sialoside groups strongly inhibit agglutination of erythrocytes by influenza virus. J. Am. Chem. Soc. 113, 686-687.
20. Lees, W. J., Spaltenstein, A., Kingery-Wood, J. E., and Whitesides, G. M. (1997) Polyacrylamides bearing pendant alpha-sialoside groups strongly inhibit agglutination of erythrocytes by influenza A virus: multivalency and steric stabilization of particulate biological systems. J. Med. Chem. 37, 3419-3433.
21. Itoh, M., Hetterich, P., Isecke, R., Brossmer, R., and Klenk, H. (1995) Suppression of influenza virus infection by an N-thioacetylneuraminic acid acrylamide copolymer resistant to neuraminidase. Virology 212, 340-347.
22. Furuike, T., Aiba, S., Suzuki, T., Takahashi, T., Suzuki, Y., and Yamada, K. (2000) Synthesis and anti-influenza virus activity of novel glycopolymers having triantennary oligosaccharide branches. J. Chem. Soc, Perkin Trans. 1, 3000-3005.
23. Mammen, M., Dahmann, G., and Whitesides, G. M. (1995) Effective inhibitors of hemagglutination by influenza virus synthesized from polymers having active ester groups. Insight into mechanism of inhibition. J. Med. Chem. 38, 4179-4190.
24. Reuter, J. D., Myc, A., Hayes, M. M., Gan, Z., Roy, R., Qin, D., Yin, R., Piehler, L. T., Esfand, R., Tomalia, D. A., and Baker, J, Jr. (1999) Inhibition of viral adhesion and infection by sialic-conjugated dendritic polymers. Bioconjugate Chem. 10, 271-278.
25. Chandrasekaran, A., Srinivasan, A., Raman, R., Viswanathan, K., Raguram, S., Tumpey, T. M., Sasisekharan, V., and Sa-sisekharan, R. (2008) Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat. Biotechnol. 26, 107-113.
26. Kato, T., Murata, T., Usui, T., and Park, E. Y. (2003) Improvement of GFPuv-β3GnT2 fusion protein production by suppressing protease in baculovirus expression system. Biosci. Biotechnol. Biochem. 67, 2388-2395.
27. Suzuki, Y., and Matsumoto, M. (1985) N-Acetylneuraminyl-lactosylceramide, GM3-NeuAc, a new influenza A virus receptor which mediates the adsorption fusion process of viral infection. Binding specificity of influenza virus A/Aichi/2/68 (H3N2) to membrane-associated GM3 with different molecular species of sialic acid. J. Biol. Chem. 260, 1362-1365.
28. Suzuki, Y., Suzuki, T., and Matsumoto, M. (1983) Isolation and characterization of receptor sialoglycoprotein for hemag-glutinating virus of Japan (Sendai virus) from bovine erythrocyte membrane. .J. Biochem. (Tokyo) 93, 1621-1633.
29. Yasuno, S., Murata, T., Kokubo, K., Yamaguchi, T., and Kamei, M. (1997) Two-mode analysis by high-performance liquid chromatography of p-aminobenzoic ethyl ester-deriva-tized monosaccharides. Biosci. Biotechnol. Biochem. 61, 1944-1946.
30. Sato, C, Inoue, S., Matsuda, T., and Kitajima, K. (1998) Development of a highly sensitive chemical method for detecting α2,8-linked oligo/polysialic acid residues in glycoproteins blotted on the membrane. Anal. Biochem. 261, 191-197.
31. Hidari, K. I.-P.J., Murata, T., Yoshida, K., Minamijima, Y., Adachi, S., Ogata, M., Usui, T., Suzuki, Y., and Suzuki, T. (2008) Chemoenzymatic synthesis, characterization, and application of glycopolymers carrying lactosamine repeats as entry inhibitors against influenza virus infection. Glycobiology 18, 779-788.
32. Peto, R., Pike, M. C, Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., and Smith, P. G. (1997) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br. J. Cancer 35, 1-39.
33. Kaplan, E. L., and Meier, P. (1958) Nonparametric estimation from incomplete observations. J. Am. Statist. Assoc. 53, 457-481.
34. Srinivasan, A., Viswanathan, K., Raman, R., Chandrasekaran, A., Raguram, S., Tumpey, T. M., Sasisekharan, V., and Sa-sisekharan, R. (2008) Quantitative biochemical rationale for differences in transmissibility of 1918 pandemic influenza A viruses. Proc. Natl. Acad. Sci. U.S.A. 105, 2800-2805.
35. Stevens, J., Blixt, O., Glaser, L., Taubenberger, J. K., Palese, P., Paulson, J. C, and Wilson, I. A. (2006) Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J. Mol. Biol. 355, 1143-1155.
36. Blixt, O., Allin, K., Bohorov, O., Liu, X., Andersson-Sand, H., Hoffmann, J., and Razi, N. (2008) Glycan microarrays for screening sialyltransferase specificities. Glycoconj. J. 25, 59-68.